New insights into cardiovascular and lipid metabolomics

Metabolomics is the study of metabolite profiles in biological samples, particularly urine, saliva, blood plasma and fat biopsies. The metabolome is now considered by some to be the most predictive phenotype: consequently, the comprehensive and quantitative study of metabolites is a desirable tool for diagnosing disease, identifying new therapeutic targets and enabling appropriate treatments. A wealth of information about metabolites has been accumulated with global profiling tools and several candidate technologies for metabolomic studies are now available. Many high‐throughput metabolomics methodologies are currently under development and have yet to be applied in clinical practice on a routine basis. In the cardiovascular field, few recent metabolomic studies have been reported so far. This minireview provides an updated overview of alternative technical approaches for metabolomics studies and reviews initial applications of metabolomics that relate to both cardiovascular disease and lipid metabolism research. J. Cell. Biochem. 105: 648–654, 2008. © 2008 Wiley‐Liss, Inc.

[1]  R. Kronmal,et al.  Cholesteryl ester transfer protein genetic polymorphisms, HDL cholesterol, and subclinical cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. , 2008, Atherosclerosis.

[2]  G. Bray,et al.  Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity , 2008, Expert review of cardiovascular therapy.

[3]  B. Astor,et al.  Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Atherosclerosis.

[4]  Claudio Napoli,et al.  Proteomics and cardiovascular disease: an update. , 2008, Current medicinal chemistry.

[5]  M. Korbonits,et al.  The role of AMP-activated protein kinase in obesity. , 2008, Frontiers of hormone research.

[6]  N. Veljkovic,et al.  Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease , 2008, Proteins.

[7]  Robert A. Harris,et al.  Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[8]  P. Ridker,et al.  A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. , 2008, Journal of the American College of Cardiology.

[9]  Marc A Pfeffer,et al.  Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. , 2008, Journal of the American College of Cardiology.

[10]  M. Sabatine,et al.  Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. , 2008, Journal of the American College of Cardiology.

[11]  Miron Livny,et al.  BioMagResBank , 2007, Nucleic Acids Res..

[12]  Tomoyoshi Soga,et al.  Metabolome analysis by capillary electrophoresis-mass spectrometry. , 2007, Journal of chromatography. A.

[13]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[14]  Xianlin Han,et al.  Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. , 2007, Analytical chemistry.

[15]  R. Caprioli,et al.  Profiling and imaging of tissues by imaging ion mobility-mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[16]  Kazuki Saito,et al.  Application of a metabolomic method combining one-dimensional and two-dimensional gas chromatography-time-of-flight/mass spectrometry to metabolic phenotyping of natural variants in rice. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  A. Woods,et al.  MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue. , 2007, Journal of mass spectrometry : JMS.

[18]  M. Orešič,et al.  Data processing for mass spectrometry-based metabolomics. , 2007, Journal of chromatography. A.

[19]  R. Goodacre,et al.  Quantitative detection of metabolites using matrix-assisted laser desorption/ionization mass spectrometry with 9-aminoacridine as the matrix. , 2007, Rapid communications in mass spectrometry : RCM.

[20]  E. K. Kemsley,et al.  Multivariate techniques and their application in nutrition: a metabolomics case study , 2007, British Journal of Nutrition.

[21]  A. Smilde,et al.  Assessing the statistical validity of proteomics based biomarkers. , 2007, Analytica chimica acta.

[22]  Xianlin Han,et al.  Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. , 2007, Biochemistry.

[23]  Joseph L. Cantone,et al.  Utility of imaging mass spectrometry (IMS) by matrix-assisted laser desorption ionization (MALDI) on an ion trap mass spectrometer in the analysis of drugs and metabolites in biological tissues. , 2007, Journal of pharmacological and toxicological methods.

[24]  R. Cox,et al.  A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. , 2007, Physiological genomics.

[25]  P. Libby,et al.  Atherosclerosis: the path from genomics to therapeutics. , 2007, Journal of the American College of Cardiology.

[26]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[27]  David S Wishart,et al.  Computational systems biology in drug discovery and development: methods and applications. , 2007, Drug discovery today.

[28]  J. van der Greef,et al.  The art and practice of systems biology in medicine: mapping patterns of relationships. , 2007, Journal of proteome research.

[29]  A. Tsantili-Kakoulidou,et al.  Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[30]  J. German,et al.  Lipidomics and lipid profiling in metabolomics , 2007, Current opinion in lipidology.

[31]  Michelle L. Reyzer,et al.  MALDI-MS-based imaging of small molecules and proteins in tissues. , 2007, Current Opinion in Chemical Biology.

[32]  Mark P. Styczynski,et al.  Systematic identification of conserved metabolites in GC/MS data for metabolomics and biomarker discovery. , 2007, Analytical chemistry.

[33]  G. Siuzdak,et al.  From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. , 2007, Journal of proteome research.

[34]  A. Tsantili-Kakoulidou,et al.  1H NMR monitoring of the canine metabolic profile after oral administration of xenobiotics using multivariate statistics. , 2007, Molecular pharmaceutics.

[35]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[36]  Jing Li,et al.  New Bioinformatics Resources For Metabolomics , 2006, Pacific Symposium on Biocomputing.

[37]  R. Kaddurah-Daouk,et al.  High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors , 2007 .

[38]  R. Kaddurah-Daouk,et al.  High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics. , 2007, Methods in molecular biology.

[39]  D. Ford,et al.  Myocardial lipidomics. Developments in myocardial nuclear lipidomics. , 2007, Frontiers in bioscience : a journal and virtual library.

[40]  Daniel Raftery,et al.  Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics , 2007, Analytical and bioanalytical chemistry.

[41]  Tomoyoshi Soga,et al.  Capillary electrophoresis-mass spectrometry for metabolomics. , 2007, Methods in molecular biology.

[42]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  Julian L Griffin,et al.  Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. , 2006, Pharmacogenomics.

[44]  A. Watson,et al.  Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .

[45]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[46]  M. Walsh,et al.  Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. , 2006, The American journal of clinical nutrition.

[47]  Nigel W. Hardy,et al.  Establishing reporting standards for metabolomic and metabonomic studies: a call for participation. , 2006, Omics : a journal of integrative biology.

[48]  L. Mueller,et al.  Metabolomic analysis using optimized NMR and statistical methods. , 2006, Analytical biochemistry.

[49]  Harald Schwalbe,et al.  Biomolecular NMR: a chaperone to drug discovery , 2006, Current Opinion in Chemical Biology.

[50]  L. Summers Adipose tissue metabolism, diabetes and vascular disease — lessons from in vivo studies , 2006, Diabetes & vascular disease research.

[51]  Frederick P Roth,et al.  Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia , 2005, Circulation.

[52]  Xianlin Han,et al.  Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. , 2005, Biochemistry.

[53]  S. Gatzek,et al.  Controlled protein precipitation in combination with chip-based nanospray infusion mass spectrometry. An approach for metabolomics profiling of plasma. , 2005, Analytical chemistry.

[54]  Xianlin Han,et al.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. , 2005, Mass spectrometry reviews.

[55]  Ronald J. Moore,et al.  Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. , 2005, Analytical chemistry.

[56]  Xianlin Han,et al.  Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.

[57]  Joachim Kopka,et al.  Metabolome analysis: the potential of in vivo labeling with stable isotopes for metabolite profiling. , 2005, Trends in biotechnology.

[58]  A. Tsantili-Kakoulidou,et al.  Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. , 2004, Free radical biology & medicine.

[59]  W. Weckwerth Metabolomics in systems biology. , 2003, Annual review of plant biology.

[60]  V. Monnier,et al.  Vitamin C metabolomic mapping in experimental diabetes with 6-deoxy-6-fluoro-ascorbic acid and high resolution 19F-nuclear magnetic resonance spectroscopy. , 2003, Metabolism: clinical and experimental.

[61]  J. Nicholson,et al.  Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics , 2002, Nature Medicine.

[62]  Xianlin Han,et al.  Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis , 2002, Journal of neurochemistry.

[63]  C. Napoli,et al.  Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. , 2001, European heart journal.

[64]  Xianlin Han,et al.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry , 2001, Journal of neurochemistry.

[65]  R. Gross,et al.  Diabetes-induced changes in specific lipid molecular species in rat myocardium. , 2000, The Biochemical journal.